1. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission;Bekker LG;Lancet,2018
2. Safety and efficacy of Elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and-experienced patients;Brehm TT;J Med
3. Catalano A. Adherence Required On Dolutegravir.
4. Cardoso TS, Costa JD, Reis EA et al. Which antiretroviral regimen is associated with higher adherence in Brazil? A comparison of single, multi, and dolutegravir-based regimens.Cad. de saude publica. 2019 Sep16;35:4 e00115518.
5. Chisholm BS, Swart AM, Blockman M. South African healthcare workers’ knowledge of dolutegravir's drug–drug interactions in the first year of its rollout: a cross-sectional online survey.J. Int. AIDS Soc.2022Mar;25(3):4 e25885.